Telix Pharmaceuticals reported AUD55.91M in Selling and Administration Expenses for its fiscal semester ending in December of 2024.


Selling And Administration Expenses Change Date
Cochlear AUD 470M 4.4M Dec/2024
CSL USD 1.18B 201M Dec/2024
Integral Diagnostics AUD 169.98M 18.73M Jun/2024
Mayne Pharma AUD 54.8M 11.94M Jun/2024
Medical Developments International AUD 12.94M 5.87M Dec/2024
Mesoblast 12.14M 662K Jun/2024
Neuren Pharmaceuticals AUD 2.33M 47K Dec/2024
Pacific Edge NZD 19.43M 12.04M Sep/2024
Paradigm Biopharmaceuticals AUD 2.36M 639.57K Dec/2024
Polynovo AUD 21.13M 18.27M Jun/2024
PYC Therapeutics AUD 2.58M 1.57M Dec/2024
Ramsay Health Care AUD 5.29B 3.2M Dec/2024
ResMed USD 265.12M 23.51M Jun/2025
Sonic Healthcare AUD 2.52B 2.46B Dec/2024